These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38280301)

  • 21. [Value of (18)F-FDG PET-CT imaging to predict epidermal growth factor receptor mutations in patients with lung squamous cell carcinoma].
    Zhao CY; Deng XY; Wang HS; Cao GP; Ding JN; Ding CY
    Zhonghua Zhong Liu Za Zhi; 2021 Jul; 43(7):795-800. PubMed ID: 34289575
    [No Abstract]   [Full Text] [Related]  

  • 22. Multiparametric FDG-PET/MRI of Hepatocellular Carcinoma: Initial Experience.
    Hectors SJ; Wagner M; Besa C; Huang W; Taouli B
    Contrast Media Mol Imaging; 2018; 2018():5638283. PubMed ID: 30402045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of diffusion-weighted MR imaging and
    Schroeder C; Lee JH; Tetzner U; Seidel S; Kim SY
    Eur J Radiol; 2020 Sep; 130():109157. PubMed ID: 32652403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Local recurrence of squamous cell carcinoma of the head and neck after radio(chemo)therapy: Diagnostic performance of FDG-PET/MRI with diffusion-weighted sequences.
    Becker M; Varoquaux AD; Combescure C; Rager O; Pusztaszeri M; Burkhardt K; Delattre BMA; Dulguerov P; Dulguerov N; Katirtzidou E; Caparrotti F; Ratib O; Zaidi H; Becker CD
    Eur Radiol; 2018 Feb; 28(2):651-663. PubMed ID: 28812148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PET measured hypoxia and MRI parameters in re-irradiated head and neck squamous cell carcinomas: findings of a prospective pilot study.
    Rogasch J; Beck M; Stromberger C; Hofheinz F; Ghadjar P; Wust P; Budach V; Amthauer H; Tinhofer I; Furth C; Walter-Rittel TC; Zschaeck S
    F1000Res; 2020; 9():1350. PubMed ID: 33796277
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of
    Yeh CH; Chan SC; Lin CY; Yen TC; Chang JT; Ko SF; Fan KH; Wang HM; Liao CT; Ng SH
    Eur J Nucl Med Mol Imaging; 2020 Jan; 47(1):94-104. PubMed ID: 31606831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [
    Crimì F; Borsetto D; Stramare R; Di Carlo R; Emauelli E; Nicolai P; Lacognata C; Zucchetta P; Oliveri G; Merola A; Bodanza V; Albertoni L; Campi C; Cecchin D
    Ann Nucl Med; 2021 Feb; 35(2):260-269. PubMed ID: 33454923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy.
    Martens RM; Noij DP; Koopman T; Zwezerijnen B; Heymans M; de Jong MC; Hoekstra OS; Vergeer MR; de Bree R; Leemans CR; de Graaf P; Boellaard R; Castelijns JA
    Eur J Radiol; 2019 Apr; 113():39-50. PubMed ID: 30927958
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Jo KH; Kim J; Cho H; Kang WJ; Lee SK; Sohn B
    Yonsei Med J; 2023 Dec; 64(12):738-744. PubMed ID: 37992746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of quantitative imaging parameters in head and neck squamous cell carcinoma.
    Gupta T; Chatterjee A; Rangarajan V; Purandare N; Arya S; Murthy V; Budrukkar A; Ghosh-Laskar S; Agarwal JP
    Q J Nucl Med Mol Imaging; 2022 Jun; 66(2):162-170. PubMed ID: 31496204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In Vivo Correlation of Glucose Metabolism, Cell Density and Microcirculatory Parameters in Patients with Head and Neck Cancer: Initial Results Using Simultaneous PET/MRI.
    Gawlitza M; Purz S; Kubiessa K; Boehm A; Barthel H; Kluge R; Kahn T; Sabri O; Stumpp P
    PLoS One; 2015; 10(8):e0134749. PubMed ID: 26270054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of integrated positron emission tomography/magnetic resonance imaging in evaluating the prognostic factors of head and neck squamous cell carcinoma with positron emission tomography, diffusion-weighted imaging, dynamic contrast enhancement and combined model.
    Dang H; Chen Y; Zhang Z; Shi X; Chen X; Zhu X; Hou B; Xing H; Xue H; Jin Z
    Dentomaxillofac Radiol; 2020 Jul; 49(5):20190488. PubMed ID: 32202922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of CT, MRI, and F-18 FDG PET/CT for initial N-staging of oral squamous cell carcinoma: a cost-effectiveness analysis.
    Burian E; Palla B; Callahan N; Pyka T; Wolff C; von Schacky CE; Schmid A; Froelich MF; Rübenthaler J; Makowski MR; Gassert FG
    Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3870-3877. PubMed ID: 35606526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole-body-MR imaging including DWIBS in the work-up of patients with head and neck squamous cell carcinoma: a feasibility study.
    Noij DP; Boerhout EJ; Pieters-van den Bos IC; Comans EF; Oprea-Lager D; Reinhard R; Hoekstra OS; de Bree R; de Graaf P; Castelijns JA
    Eur J Radiol; 2014 Jul; 83(7):1144-1151. PubMed ID: 24768188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.
    Suenaga Y; Kitajima K; Ishihara T; Sasaki R; Otsuki N; Nibu K; Minamikawa T; Kiyota N; Sugimura K
    Eur Radiol; 2016 Apr; 26(4):1018-30. PubMed ID: 26188656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of [¹⁸F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer.
    Caicedo C; Garcia-Velloso MJ; Lozano MD; Labiano T; Vigil Diaz C; Lopez-Picazo JM; Gurpide A; Zulueta JJ; Richter Echevarria JA; Perez Gracia JL
    Eur J Nucl Med Mol Imaging; 2014 Nov; 41(11):2058-65. PubMed ID: 24990403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of residual head and neck squamous cell carcinoma after (chemo)radiotherapy: a pilot study assessing the value of diffusion-weighted magnetic resonance imaging as an adjunct to PET-CT using
    Noij DP; Jagesar VA; de Graaf P; de Jong MC; Hoekstra OS; de Bree R; Castelijns JA
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Sep; 124(3):296-305.e2. PubMed ID: 28539202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of the treatment outcome using machine learning with FDG-PET image-based multiparametric approach in patients with oral cavity squamous cell carcinoma.
    Fujima N; Andreu-Arasa VC; Meibom SK; Mercier GA; Salama AR; Truong MT; Sakai O
    Clin Radiol; 2021 Sep; 76(9):711.e1-711.e7. PubMed ID: 33934877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results.
    Heusch P; Buchbender C; Köhler J; Nensa F; Beiderwellen K; Kühl H; Lanzman RS; Wittsack HJ; Gomez B; Gauler T; Schuler M; Forsting M; Bockisch A; Antoch G; Heusner TA
    Rofo; 2013 Nov; 185(11):1056-62. PubMed ID: 23860802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.